| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $2,676,236 | 9 | 100 |
Sells | $0 | 0 | 0 |
| Hayden Michael R | director | 2 | $1.05M | 0 | $0 | $1.05M |
| Thermopylae Holdings Ltd. | 10 percent owner | 2 | $711,004 | 0 | $0 | $711,004 |
| Booth Andrew | Chief Financial Officer | 2 | $529,596 | 0 | $0 | $529,596 |
| Montalbano John S. | director | 3 | $384,160 | 0 | $0 | $384,160 |
AbCellera Biologics Inc. specializes in pioneering an advanced platform for the discovery of antibodies. This comprehensive, AI-driven system meticulously explores and analyzes natural immune systems to identify antibodies suitable for the creation of new pharmaceutical drugs. As of December 31, 2021, the company had cultivated 156 discovery programs, ranging from completed to in-progress or under contract, in partnership with 36 entities. Notably, AbCellera maintains a crucial research collaboration and license agreement with Eli Lilly and …
Over the last 12 months, insiders at AbCellera Biologics Inc. have bought $2.68M and sold $0 worth of AbCellera Biologics Inc. stock.
On average, over the past 5 years, insiders at AbCellera Biologics Inc. have bought $5.87M and sold $0 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Hayden Michael R (director) — $1.05M. Thermopylae Holdings Ltd. (10 percent owner) — $711,004. Booth Andrew (Chief Financial Officer) — $529,596.
The last purchase of 53,613 shares for transaction amount of $570,442 was made by Hayden Michael R (director) on 2026‑08‑24.
| 2026-08-24 | Hayden Michael R | director | 53,613 0.0176% | $10.64 | $570,442 | +15.83% | ||
| 2026-08-18 | Montalbano John S. | director | 10,000 0.0032% | $11.03 | $110,300 | +10.07% | ||
| 2026-08-14 | Booth Andrew | Chief Financial Officer | 37,200 0.011% | $10.32 | $383,904 | +7.29% | ||
| 2026-08-12 | Hayden Michael R | director | 46,387 0.0152% | $10.37 | $481,033 | +17.08% | ||
| 2026-05-14 | Montalbano John S. | director | 20,000 0.0071% | $4.77 | $95,400 | +121.82% | ||
| 2026-02-27 | Thermopylae Holdings Ltd. | 10 percent owner | 38,000 0.0121% | $3.44 | $130,720 | +64.68% | ||
| 2026-02-27 | Booth Andrew | Chief Financial Officer | 42,600 0.0135% | $3.42 | $145,692 | +64.68% | ||
| 2026-02-26 | Thermopylae Holdings Ltd. | 10 percent owner | 177,457 0.054% | $3.27 | $580,284 | +64.90% | ||
| 2025-11-26 | Montalbano John S. | director | 50,000 0.0164% | $3.57 | $178,460 | +39.15% | ||
| 2025-03-11 | Thermopylae Holdings Ltd. | 10 percent owner | 343,631 0.1117% | $2.16 | $742,243 | +63.68% | ||
| 2025-03-10 | Montalbano John S. | director | 25,000 0.0088% | $2.30 | $57,500 | +65.91% | ||
| 2025-03-06 | Montalbano John S. | director | 60,000 0.0198% | $2.34 | $140,568 | +53.36% | ||
| 2024-08-29 | Thermopylae Holdings Ltd. | 10 percent owner | 283,516 0.0993% | $2.61 | $739,977 | +10.08% | ||
| 2023-11-08 | Montalbano John S. | director | 10,000 0.0037% | $4.46 | $44,600 | -7.89% | ||
| 2023-11-06 | Montalbano John S. | director | 20,000 0.0071% | $4.64 | $92,800 | -13.76% | ||
| 2023-09-22 | Hayden Michael R | director | 20,000 0.0066% | $4.91 | $98,200 | -14.30% | ||
| 2023-09-12 | Lecault Veronique | Chief Operating Officer | 20,000 0.007% | $5.19 | $103,800 | -15.56% | ||
| 2023-08-08 | Hayden Michael R | director | 30,000 0.0104% | $5.90 | $177,000 | -23.77% | ||
| 2023-05-26 | Thermopylae Holdings Ltd. | 10 percent owner | 153,000 0.051% | $6.52 | $997,728 | -26.25% | ||
| 2023-05-26 | Booth Andrew | Chief Financial Officer | 14,500 0.0051% | $6.85 | $99,325 | -26.25% |
| Thermopylae Holdings Ltd. | 10 percent owner | 56134097 17.3228% | $683.71M | 13 | 1 | +11.9% |
| Hayden Michael R | director | 1373397 0.4238% | $16.73M | 5 | 1 | <0.0001% |
| Booth Andrew | Chief Financial Officer | 482800 0.149% | $5.88M | 5 | 1 | <0.0001% |
| Montalbano John S. | director | 251000 0.0775% | $3.06M | 11 | 0 | +5.04% |
| THIEL PETER | director | 10179880 3.1415% | $123.99M | 1 | 0 | <0.0001% |
| Lecault Veronique | Chief Operating Officer | 2040122 0.6296% | $24.85M | 4 | 1 | <0.0001% |
| Stimart Tryn | Chief Legal Officer | 250 0.0001% | $3,045.00 | 1 | 1 | <0.0001% |
$11,583,737 | 45 | 49.75% | $4.66B | |
$104,428,685 | 44 | 22.55% | $3.78B | |
$1,275,975,557 | 32 | 19.44% | $3.54B | |
AbCellera Biologics Inc. (ABCL) | $151,136,640 | 31 | -1.41% | $3.95B |
$5,066,938 | 27 | 26.38% | $3.7B |
| Increased Positions | 80 | +50.31% | 23M | +22.4% |
| Decreased Positions | 67 | -42.14% | 20M | -18.8% |
| New Positions | 30 | New | 11M | New |
| Sold Out Positions | 27 | Sold Out | 15M | Sold Out |
| Total Postitions | 172 | +8.18% | 108M | +3.6% |
| Baker Bros. Advisors Lp | $94,413.00 | 9.21% | 27.53M | 0 | 0% | 2025-09-30 |
| Capital World Investors | $45,829.00 | 4.47% | 13.36M | 0 | 0% | 2025-09-30 |
| Baillie Gifford & Co | $35,751.00 | 3.49% | 10.42M | +62,962 | +0.61% | 2025-09-30 |
| Two Sigma Investments, Lp | $17,751.00 | 1.73% | 5.18M | +1M | +25.89% | 2025-09-30 |
| Two Sigma Advisers, Lp | $16,464.00 | 1.61% | 4.8M | +729,600 | +17.93% | 2025-09-30 |
| Arrowmark Colorado Holdings Llc | $14,080.00 | 1.37% | 4.11M | 0 | 0% | 2025-09-30 |
| Blackrock, Inc. | $12,491.00 | 1.22% | 3.64M | -39,015 | -1.06% | 2025-09-30 |
| Renaissance Technologies Llc | $11,527.00 | 1.12% | 3.36M | +53,300 | +1.61% | 2025-09-30 |
| Morgan Stanley | $9,577.00 | 0.93% | 2.79M | +2M | +180.07% | 2025-09-30 |
| Tang Capital Management Llc | $8,918.00 | 0.87% | 2.6M | 0 | 0% | 2025-09-30 |